Digital

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline
AIAI Proteins

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Astellas Pharma Inc. (TYO: 4503) announced a collaboration with AI Proteins, a Boston‑based computational drug discovery company, in a deal with a total potential value exceeding USD 400 million. Under…

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
BiotechE-commerce

Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online

JD HealthcareJD.com

JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF

Dian DiagnosticsSHE: 300244

Zhejiang Dian Diagnostics Partners with Haihe Laboratory to Advance Hematology Diagnostics

Baidu Health

Baidu Health Partners with Yibang to Enhance Operations for Brick-and-Mortar Pharmacies

Show More